147 related articles for article (PubMed ID: 30867098)
1. Selective serotonin reuptake inhibitors during pregnancy Do not increase the risk of Hirschsprung disease.
Granström AL; Skoglund C; Wester T
J Pediatr Surg; 2019 Nov; 54(11):2398-2401. PubMed ID: 30867098
[TBL] [Abstract][Full Text] [Related]
2. Maternal Risk Factors and Perinatal Characteristics for Hirschsprung Disease.
Löf Granström A; Svenningsson A; Hagel E; Oddsberg J; Nordenskjöld A; Wester T
Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27307146
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
4. Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort study.
Upadhyaya S; Brown A; Cheslack-Postava K; Gissler M; Gyllenberg D; Heinonen E; Laitinen J; McKeague I; Hinkka-Yli-Salomäki S; Sourander A; Tornio A; Malm H
Reprod Toxicol; 2023 Jun; 118():108365. PubMed ID: 36958464
[TBL] [Abstract][Full Text] [Related]
5. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
6. Maternal Use of Selective Serotonin Reuptake Inhibitors and Lengthening of the Umbilical Cord: Indirect Evidence of Increased Foetal Activity-A Retrospective Cohort Study.
Kivistö J; Lehto SM; Halonen K; Georgiadis L; Heinonen S
PLoS One; 2016; 11(4):e0154628. PubMed ID: 27128030
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
[TBL] [Abstract][Full Text] [Related]
8. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
[TBL] [Abstract][Full Text] [Related]
9. SSRI antidepressants and persistent pulmonary hypertension in newborns.
Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Study Evaluating the Effects of SSRI Exposure on Cardiac Size and Function in Newborns.
Ansah DA; Reinking BE; Colaizy TT; Roghair RD; Haskell SE
Neonatology; 2019; 115(4):320-327. PubMed ID: 30836356
[TBL] [Abstract][Full Text] [Related]
11. SSRI use during pregnancy and risk for postpartum haemorrhage: a national register-based cohort study in Sweden.
Skalkidou A; Sundström-Poromaa I; Wikman A; Hesselman S; Wikström AK; Elenis E
BJOG; 2020 Oct; 127(11):1366-1373. PubMed ID: 32162458
[TBL] [Abstract][Full Text] [Related]
12. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors' passage into human milk of lactating women.
Pogliani L; Baldelli S; Cattaneo D; Pileri P; Clementi E; Cetin I; Zuccotti G
J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3020-3025. PubMed ID: 29557689
[No Abstract] [Full Text] [Related]
14. Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung's disease in newborns - a nationwide cohort study.
Nielsen SW; Ljungdalh PM; Nielsen J; Nørgård BM; Qvist N
Orphanet J Rare Dis; 2017 Jun; 12(1):116. PubMed ID: 28633635
[TBL] [Abstract][Full Text] [Related]
15. Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.
Yazdy MM; Mitchell AA; Louik C; Werler MM
Epidemiology; 2014 Nov; 25(6):859-65. PubMed ID: 25171134
[TBL] [Abstract][Full Text] [Related]
16. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
Källén BA; Otterblad Olausson P
Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):301-8. PubMed ID: 17216624
[TBL] [Abstract][Full Text] [Related]
17. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study.
Lindqvist PG; Nasiell J; Gustafsson LL; Nordstrom L
J Thromb Haemost; 2014 Dec; 12(12):1986-92. PubMed ID: 25322909
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
20. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
